Placebo News and Research

RSS

Eczema drug alleviates asthma symptoms and improves lung function

Two new studies of patients with difficult-to-control asthma show that the eczema drug dupilumab alleviates asthma symptoms and improves patients' ability to breathe better than standard therapies.

22 May 2018

PSCK9 inhibitors may provide benefit to atherosclerosis patients with high lipoprotein(a) levels

Lipoprotein(a) is a variant of LDL (low-density lipoprotein) cholesterol, and large amounts of data have shown that higher lipoprotein(a) levels are associated with an increased risk of cardiovascular events.

22 May 2018

FDA approves new drug to treat thrombocytopenia in adults with chronic liver disease

The U.S. Food and Drug Administration today approved Doptelet (avatrombopag) tablets to treat low blood platelet count (thrombocytopenia) in adults with chronic liver disease who are scheduled to undergo a medical or dental procedure. This is the first drug approved by the FDA for this use.

22 May 2018

Study: Prediabetic patients with OSA could lower their resting heart rates by using CPAP

Patients with prediabetes who also have obstructive sleep apnea may improve their resting heart rate, an important measure of cardiovascular health, by using continuous positive airway pressure to treat their OSA, according to a randomized, controlled trial presented at the ATS 2018 International Conference.

21 May 2018

Clinical trial begins enrollment to test safety of experimental MERS treatments

Enrollment has begun in an early-stage clinical trial testing the safety of two human monoclonal antibodies (mAbs) designed to treat people infected with Middle East respiratory syndrome coronavirus (MERS-CoV).

18 May 2018

Study: Psoriasis patients taking Humira show no change in aortic inflammation

An antibody used to treat the skin disease psoriasis and other chronic autoimmune diseases such as rheumatoid arthritis and inflammatory bowel disease has no effect on aortic inflammation – a key marker of future risk of major cardiovascular events – unlike other antibodies that target different aspects of the immune system.

18 May 2018

Guideline revisions for knee osteoarthritis have 'subtle but significant' impact on clinical practice

Recent updates in evidence-based recommendations have led to changes in the use of steroid and hyaluronic acid injection for patients with osteoarthritis of the knee, reports a study in the May 16, 2018 issue of The Journal of Bone & Joint Surgery.

18 May 2018

Clot busting drug combo reduces risk of major strokes in high risk patients

In patients who have had a minor stroke or a transient ischemic stroke (TIA), the risk of getting a full-blown stroke or a major stroke is high. A new study has found that these high-risk individuals, when prescribed with clot-preventing drugs clopidogrel along with aspirin show a lower risk of getting major stroke.

18 May 2018

FDA OKs first non-opioid drug for adults with opioid withdrawal symptoms

The United States Food and Drugs Administration (FDA), in a statement this week, approved a new drug Lucemyra (lofexidine hydrochloride) for the treatment and alleviation of opioid symptom withdrawal symptoms in adults in whom the drugs have been withdrawn abruptly.

17 May 2018

Sleep deprivation study to pinpoint brain processes causing poor decision-making

Sleep deprivation can take a heavy toll on our ability to make sound decisions, with potentially disastrous outcomes.

17 May 2018

Pfizer announces Phase 3 study results of LYRICA Oral Solution CV for pediatric epilepsy patients

Pfizer Inc. announced today positive top-line results of a Phase 3 study examining the use of LYRICA® Oral Solution CV as adjunctive therapy for partial onset seizures in pediatric epilepsy patients one month to less than four years of age.

17 May 2018

International study finds viable treatment option for people with mild asthma

A large international study led by a Hamilton researcher has found a patient-centric treatment that works for people with mild asthma.

17 May 2018

Study finds molecular handle that chikungunya virus uses to enter into cells and cause arthritis

Chikungunya virus is a growing threat to the United States and other regions of the world as the mosquito that carries the virus expands its reach. Telltale symptoms of chikungunya infection are fever and joint pain that last about a week.

17 May 2018

FDA approves new treatment to mitigate opioid withdrawal symptoms in adults

The U.S. Food and Drug Administration today approved Lucemyra (lofexidine hydrochloride) for the mitigation of withdrawal symptoms to facilitate abrupt discontinuation of opioids in adults.

17 May 2018

Taking clot-preventing drug with aspirin may lower risk of major stroke, finds study

The research was part of the Platelet-Oriented Inhibition in New TIA and minor ischemic stroke trial -- a randomized, double-blind, placebo-controlled trial conducted between May 2010 and December 2017.

16 May 2018

Study: Drug used to treat blood loss may be beneficial for some stroke patients

Patients with stroke caused by bleeding on the brain may benefit from receiving a drug currently used to treat blood loss from major trauma and bleeding after childbirth, an international trial has revealed.

16 May 2018

Phase 1/2 study evaluates safety, tolerability of multiple-ascending doses of ARO-HBV in hepatitis B patients

Arrowhead Pharmaceuticals Inc. today announced that it has dosed the first 3 hepatitis B virus patients in the multiple-ascending dose portion of its ongoing Phase 1/2 study of ARO-HBV, the company's third generation subcutaneously administered RNA interference therapeutic being developed as a potentially curative therapy for patients with chronic HBV infection.

14 May 2018

Placebo News and Research

Eczema drug alleviates asthma symptoms and improves lung function

PSCK9 inhibitors may provide benefit to atherosclerosis patients with high lipoprotein(a) levels

FDA approves new drug to treat thrombocytopenia in adults with chronic liver disease

Study: Prediabetic patients with OSA could lower their resting heart rates by using CPAP

Clinical trial begins enrollment to test safety of experimental MERS treatments

Study: Psoriasis patients taking Humira show no change in aortic inflammation

Guideline revisions for knee osteoarthritis have 'subtle but significant' impact on clinical practice

Clot busting drug combo reduces risk of major strokes in high risk patients

FDA OKs first non-opioid drug for adults with opioid withdrawal symptoms

Sleep deprivation study to pinpoint brain processes causing poor decision-making

Pfizer announces Phase 3 study results of LYRICA Oral Solution CV for pediatric epilepsy patients

International study finds viable treatment option for people with mild asthma

Study finds molecular handle that chikungunya virus uses to enter into cells and cause arthritis

FDA approves new treatment to mitigate opioid withdrawal symptoms in adults

Taking clot-preventing drug with aspirin may lower risk of major stroke, finds study

Study: Drug used to treat blood loss may be beneficial for some stroke patients

Phase 1/2 study evaluates safety, tolerability of multiple-ascending doses of ARO-HBV in hepatitis B patients

Human papilloma virus vaccines can protect against cervical lesions in young women

Study compares effectiveness of vaginal estradiol tablets and moisturizers in treating vulvovaginal problems

EPO's neuroprotective effect in preemies may be mediated by epigenetic regulation of genes

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Advancing Intracellular Delivery with LumiPore®

Latest News